- Home
- EZGO vs CRIS Comparison
EZGO vs CRIS Comparison
Compare EZGO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EZGO | CRIS |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.0M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EZGO | CRIS |
|---|---|---|
| Price | $0.93 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | ★ 234.5K | 164.7K |
| Earning Date | 08-14-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.01 | $0.18 |
| 52 Week High | $3.30 | $6.74 |
Technical Indicators
Market Signals| Indicator | EZGO | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 19.46 |
| Support Level | $0.83 | $0.34 |
| Resistance Level | $1.30 | $5.50 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.01 | 1.45 |
| Stochastic Oscillator | 33.63 | 11.77 |
Price Performance
Historical ComparisonAbout EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.